VIANEWS – The Innrs algorithm for artificial intelligence suggested yesterday a handful of financial assets that could make investors profit.

Via News provides daily facts about an AI algorithm used to forecast the price of financial assets and their trend for next week.

Innrs offers AI-based statistical tools that help investors make better decisions.

You would get a return of 0.07 if you invested in the Innrs AI prediction from last session.

Financial Asset Accuracy Previous Close Prediction Close Price ROI
Geo Group (GEO) 87.17% $9.78 $9.81 $10.44 6.75% ✅
Cenovus Energy (CVE) 88.09% $20.22 $19.65 $19.74 2.37% ✅
Broadridge Financial Solutions (BR) 83.76% $144.17 $147.34 $147.1 2.03% ✅
AbbVie (ABBV) 89.04% $154.78 $156.94 $157.11 1.51% ✅
Merck (MRK) 83.7% $104.36 $105.66 $105.61 1.2% ✅
American Airlines (AAL) 87.99% $14.01 $13.76 $13.85 1.14% ✅
Gilead Sciences (GILD) 88.65% $83.41 $85.26 $84.35 1.13% ✅
White Mountains Insurance Group (WTM) 83.66% $1335.79 $1364 $1350.08 1.07% ✅
Kinder Morgan (KMI) 88.75% $18.42 $18.32 $18.28 0.76% ✅
Generac Holdlings (GNRC) 86.05% $103.32 $99.12 $102.57 0.73% ✅
Fifth Third Bancorp (FITBI) 84.26% $25.47 $25.55 $25.5 0.12% ✅
Rogers Communication (RCI) 83.95% $44.53 $45.45 $44.58 0.11% ✅
Johnson & Johnson (JNJ) 88.59% $176.19 $178.94 $175.97 -0.12%
Eli Lilly and Company (LLY) 83.44% $361.8 $362.59 $361.17 -0.17%
Comcast Corporation (CMCSA) 88.27% $34.42 $35.67 $34.35 -0.2%
Biogen (BIIB) 83.78% $302.92 $309.97 $301.63 -0.43%
International Business Machines (IBM) 88.85% $147.74 $150.43 $146.68 -0.72%
Genmab (GMAB) 88.64% $43.76 $44.64 $43.44 -0.73%
AT&T (T) 84.26% $18.99 $19.23 $18.84 -0.79%
Enphase Energy (ENPH) 93.13% $312.11 $314.27 $308.1 -1.28%
STMicroelectronics (STM) 88.02% $38.22 $38.89 $37.71 -1.33%
AMD (AMD) 87.15% $73.58 $77.22 $72.46 -1.52%
TE Connectivity (TEL) 83.28% $126.67 $131.27 $124.69 -1.56%
Lumen Technologies (LUMN) 88.46% $5.88 $5.94 $5.76 -2.04%
Visa (V) 88.76% $211.37 $215.71 $206.32 -2.39%
Amkor Technology (AMKR) 87.31% $28.32 $29.82 $27.27 -3.71%

1. Geo Group (GEO)

Shares of Geo Group rose by a staggering 21.14% in from $8.61 to $10.43 at 21:29 EST on Monday, after five sequential sessions in a row of gains. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom.

Earnings per Share

Geo Group’s trailing twelve-month EPS is $0.94.

PE Ratio

Geo Group’s trailing 12-month price-earnings ratio is 11.09. The purchaser of the shares is therefore investing $11.09 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 7.46%.

Growth Estimates Quarters

For the current quarter, the company expects a decline of 31.6% in growth and a rise of 19.2% the following.

More news about Geo Group.

2. Cenovus Energy (CVE)

Shares of Cenovus Energy rose 3.46% in from $19.09 to $19.75 at 21:29 EST on Monday, after four consecutive sessions in a row of losses. NYSE is dropping 0.21% to $15,278.26, following the last session’s downward trend.

Cenovus Energy Inc., together with its subsidiaries, develops, produces, and markets crude oil, natural gas liquids, and natural gas in Canada, the United States, and the Asia Pacific region.

Earnings per Share

Cenovus Energy’s trailing 12 months EPS is $-1.58.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 16.83%.

More news about Cenovus Energy.

3. Broadridge Financial Solutions (BR)

Shares of Broadridge Financial Solutions rose 3.59% in from $142.21 to $147.32 at 21:29 EST on Monday, after four consecutive sessions in a row of gains. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

Broadridge Financial Solutions, Inc. provides investor communications and technology-driven solutions for the financial services industry.

Earnings Per Share

As for profitability, Broadridge Financial Solutions has a trailing twelve months EPS of $4.43.

PE Ratio

Broadridge Financial Solutions has a trailing twelve months price to earnings ratio of 33.29. Meaning,
the purchaser of the share is investing $33.29 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.34%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 20.1% and a drop 6.5% for the next.

Dividend Yield

Morningstar, Inc. claims that the next dividend payment will be on Jun 13, 2022. The forward dividend rate and yield are both 2.56 and 1.59% respectively.

Annual Top and Bottom Value

Broadridge Financial Solutions stock was valued at $177.32 at 21.29 EST at 21:29 EST. This is way lower than the 52-week high $185.40, and much higher than the 52-week low $131.35.

Volume

Broadridge Financial Solutions’ last reported volume is now 244090, which is just 59.08% lower than its average volume at 596595.

More news about Broadridge Financial Solutions.

4. AbbVie (ABBV)

Shares of AbbVie jumped 4.24% in from $150.82 to $157.21 at 21:29 EST on Monday, after three sequential sessions in a row of gains. NYSE is sliding 0.21% to $15,278.26, following the last session’s downward trend.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.

Earnings per Share

AbbVie’s trailing twelve-month EPS is $2.91.

PE Ratio

AbbVie’s trailing 12-month price-to-earnings ratio is 53.97. The purchaser of the shares is therefore investing $53.97 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 92.71%.

Sales Growth

AbbVie’s sales growth for the next quarter is 6%.

Moving Average

AbbVie is worth more than its $50-day average value of $144.85, and greater than its $200-day average value of $148.32.

Volume

Today’s last reported volume for AbbVie is 4760660 which is 13.24% below its average volume of 5487510.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AbbVie’s stock is considered to be oversold (<=20).

More news about AbbVie.

5. Merck (MRK)

Shares of Merck jumped 8.33% in from $97.44 to $105.56 at 21:29 EST on Monday, after four successive sessions in a row of gains. NYSE is dropping 0.21% to $15,278.26, following the last session’s downward trend.

Merck & Co., Inc. operates as a healthcare company worldwide.

Earnings Per Share

As for profitability, Merck has a trailing twelve months EPS of $2.77.

PE Ratio

Merck has a trailing twelve months price to earnings ratio of 38.12. Meaning,
the purchaser of the share is investing $38.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.42%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Sep 13, 2022, the estimated forward annual dividend rate is 2.76 and the estimated forward annual dividend yield is 2.82%.

Previous days news about Merck

  • Imago biosciences stock soars after Merck bids more than 100% premium to buy the biotech. According to MarketWatch on Monday, 21 November, "We continue to invest in our pipeline with a focus on applying our unique capabilities to unlock the value of breakthrough science for the patients we serve," said Merck Chief Executive Robert Davis. ", "Under terms of the deal, Merck will pay $36.00 for each Imago share, which represents a 106.9% premium to Friday’s closing price of $17.40. "
  • Merck to buy imago biosciences for more than double Friday's price. According to MarketWatch on Monday, 21 November, "Shares of Imago BioSciences Inc. soared toward an eight-month high in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other bone marrow diseases announced an agreement to be acquired by Merck & Co. Inc. in a cash deal with a equity value of $1.35 billion. ", "We continue to invest in our pipeline with a focus on applying our unique capabilities to unlock the value of breakthrough science for the patients we serve," said Merck Chief Executive Robert Davis. "

More news about Merck.

6. American Airlines (AAL)

Shares of American Airlines slid 0.36% in from $14.1 to $14.05 at 21:29 EST on Monday, following the last session’s downward trend. NASDAQ is dropping 1.09% to $11,024.51, following the last session’s downward trend.

American Airlines Group Inc. operates through its subsidiaries as a network airline carrier.

Earnings per Share

American Airlines’ trailing 12 months profit per share is $-14.73

Volume

American Airlines’ last reported volume is currently 11315200, which is 64.85% less than its average volume 32198500.

Revenue Growth

Year-on-year quarterly revenue growth grew by 50.1%, now sitting on 45.21B for the twelve trailing months.

Sales Growth

American Airlines’s sales growth is 34.7% for the ongoing quarter and 31.9% for the next.

More news about American Airlines.

7. Gilead Sciences (GILD)

Shares of Gilead Sciences rose by a staggering 22.46% in from $69 to $84.50 at 21:29 EST on Monday, following the last session’s upward trend. NASDAQ is sliding 1.09% to $11,024.51, following the last session’s downward trend.

Gilead Sciences, Inc., is a biopharmaceutical firm that discovers, develops, commercializes and markets medicines in areas where there are unmet medical needs in the United States, Europe, or internationally.

Earnings per Share

For profitability, Gilead Sciences’ trailing twelve-month EPS is $0.24

PE Ratio

Gilead Sciences’ trailing 12-month price-earnings ratio is 352.06. The purchaser of the shares is therefore investing $352.06 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 20.58%.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 101.4% while it will see a decrease of 24.1% in the following.

More news about Gilead Sciences.

8. White Mountains Insurance Group (WTM)

Shares of White Mountains Insurance Group rose 1.98% in from $1319.45 to $1,345.58 at 21:29 EST on Monday, after two consecutive sessions in a row of losses. NYSE is dropping 0.21% to $15,278.26, following the last session’s downward trend.

White Mountains Insurance Group, Ltd., through its subsidiaries, provides insurance and other financial services in the United States.

Earnings per Share

White Mountains Insurance Group’s trailing 12 months profit per share is $226.97.

PE Ratio

White Mountains Insurance Group’s trailing 12-month price-earnings ratio is 5.93. The purchaser of the shares is investing $5.93 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was negative at -5.88%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

White Mountains Insurance Group’s stock is considered to be oversold (<=20).

Moving Average

White Mountains Insurance Group is worth more than its moving average for 50 days of $1305.18, and much higher than that of its moving average for 200 days of $1152.98.

More news about White Mountains Insurance Group.

9. Kinder Morgan (KMI)

Shares of Kinder Morgan rose 5.97% in from $17.25 to $18.28 at 21:29 EST on Monday, following the last session’s downward trend. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

Kinder Morgan, Inc. operates as an energy infrastructure company in North America.

Earnings per Share

Kinder Morgan’s trailing 12 months profit per share was $0.8.

PE Ratio

Kinder Morgan’s trailing 12-month price-to-earnings ratio is 22.77. The purchaser of the shares is therefore investing $22.77 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is an indicator of the business’ profitability relative to shareholders’ equity, was 8.1%.

Moving Average

Kinder Morgan is worth more than its moving average for 50 days of $17.65, and its moving average for 200 days of $18.04.

Dividend Yield

According to Morningstar, Inc., there will be a next dividend payment on October 27, 2022. The forward dividend rate for 2020 is estimated at 1.11, and the forward dividend yield at 6.26%.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 14.8% while it will see a decline of 3.1% in the following.

Sales Growth

Kinder Morgan’s sales growth is 10.1% for the ongoing quarter and 33.3% for the next.

More news about Kinder Morgan.

10. Generac Holdlings (GNRC)

Shares of Generac Holdlings fell by a staggering 11.94% in from $114.97 to $101.24 at 21:29 EST on Monday, after two sequential sessions in a row of losses. NYSE is sliding 0.21% to $15,278.26, following the last session’s downward trend.

Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide.

Earnings Per Share

As for profitability, Generac Holdlings has a trailing twelve months EPS of $7.12.

PE Ratio

Generac Holdlings has a trailing twelve months price to earnings ratio of 14.21. Meaning,
the purchaser of the share is investing $14.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.39%.

Annual Top and Bottom Value

Generac Holdings’ stock was valued at $101.24 as of 21:30 EST. This is way lower than its 52 week high of $463.46, and higher than its 52-week low $98.65.

Volume

Today’s last reported volume for Generac Holdlings is 331353 which is 84.04% below its average volume of 2077410.

Revenue growth

The year-on-year revenue growth was 40.7%. We now have 4.07B in the 12 trailing months.

Sales Growth

Generac Holdlings’s sales growth is 37.5% for the ongoing quarter and 41.3% for the next.

More news about Generac Holdlings.

11. Fifth Third Bancorp (FITBI)

Shares of Fifth Third Bancorp rose 2.79% in from $24.7 to $25.39 at 21:29 EST on Monday, after two consecutive sessions in a row of gains. NASDAQ is dropping 1.09% to $11,024.51, following the last session’s downward trend.

Fifth Third Bank is as innovative as its history.

Earnings Per Share

As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $2.72.

PE Ratio

Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 9.33. Meaning,
the purchaser of the share is investing $9.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.08%.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

Fifth Third Bancorp stock considered oversold (=20).

More news about Fifth Third Bancorp.

12. Rogers Communication (RCI)

Shares of Rogers Communication jumped by a staggering 15.36% in from $38.81 to $44.77 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is sliding 0.21% to $15,278.26, following the last session’s downward trend.

Rogers Communications Inc. is a Canadian communications and media company.

Earnings Per Share

As for profitability, Rogers Communication has a trailing twelve months EPS of $2.57.

PE Ratio

Rogers Communication has a trailing twelve months price to earnings ratio of 17.4. Meaning,
the purchaser of the share is investing $17.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.22%.

Sales Growth

Rogers Communication’s sales growth is 2% for the current quarter and 1.8% for the next.

Moving Average

Rogers Communication’s value has risen to a level that is higher than its $50.52 moving average and lower than its $200 moving average at $48.15.

More news about Rogers Communication.

13. Johnson & Johnson (JNJ)

Shares of Johnson & Johnson jumped 3.04% in from $170.85 to $176.04 at 21:29 EST on Monday, following the last session’s downward trend. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

Johnson & Johnson and its affiliates research, develop, produce, and market various healthcare products around the world.

Earnings Per Share

As for profitability, Johnson & Johnson has a trailing twelve months EPS of $5.66.

PE Ratio

Johnson & Johnson has a trailing twelve months price to earnings ratio of 31.1. Meaning,
the purchaser of the share is investing $31.1 for every dollar of annual earnings.

Volume

Today’s last reported volume for Johnson & Johnson is 4004950 which is 43.04% below its average volume of 7032380.

More news about Johnson & Johnson.

14. Eli Lilly and Company (LLY)

Shares of Eli Lilly and Company rose 3.68% in from $348.05 to $360.86 at 21:29 EST on Monday, following the last session’s downward trend. NYSE is dropping 0.21% to $15,278.26, following the last session’s downward trend.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.

Earnings per Share

For profitability, Eli Lilly and Company have a trailing 12 month EPS of $6.68

PE Ratio

Eli Lilly and Company’s trailing 12-month price-earnings ratio is 54.02. The purchaser of the shares is therefore investing $54.02 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 74.29%.

Revenue growth

The year-on-year revenue growth fell by 3.7%. We now have 29.07B in the 12 trailing months.

More news about Eli Lilly and Company.

15. Comcast Corporation (CMCSA)

Shares of Comcast Corporation jumped by a staggering 11.05% in from $31.03 to $34.46 at 21:29 EST on Monday, following the last session’s downward trend. NASDAQ is sliding 1.09% to $11,024.51, following the last session’s downward trend.

Comcast Corporation operates as a media and technology company worldwide.

Earnings per Share

Comcast Corporation’s trailing 12 months EPS is $2.53.

PE Ratio

Comcast Corporation’s trailing 12-month price-to-earnings ratio is 13.62. The purchaser of the shares is therefore investing $13.62 per dollar in annual earnings.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 2, 2023, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 3.43%.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 5.2% and 5.8% respectively.

Moving Average

Comcast Corporation’s worth is above its 50-day moving average of $31.75 and way below its 200-day moving average of $39.91.

More news about Comcast Corporation.

16. Biogen (BIIB)

Shares of Biogen jumped by a staggering 10.6% in from $274.92 to $304.06 at 21:29 EST on Monday, following the last session’s downward trend. NASDAQ is sliding 1.09% to $11,024.51, following the last session’s downward trend.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases.

Earnings per Share

Biogen’s trailing 12 months profit per share is $19.29

PE Ratio

Biogen’s trailing 12-month price-earnings ratio is 15.76. The purchaser of the shares is therefore investing $15.76 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 20.23%.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 2.7% and 10.5% respectively.

More news about Biogen.

17. International Business Machines (IBM)

Shares of International Business Machines jumped by a staggering 11.17% in from $132.62 to $147.43 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is sliding 0.21% to $15,278.26, following the last session’s downward trend.

International Business Machines Corporation offers integrated solutions and global services.

Earnings per Share

International Business Machines’ trailing 12 months profit per share was $5.98.

PE Ratio

International Business Machines’ trailing 12 months earnings to price ratio is 24.66. The purchaser of the shares is therefore investing $24.66 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability of a business relative shareholder equity, was 27.09%.

Volatility

International Business Machines’s intraday variation average for the week and quarter ended December 31, 2016, 0.63% and 1.22%, respectively.

International Business Machines had the highest average volatility amplitudes of 0.76%, 1.13% and 1.22% in the last week.

Sales Growth

International Business Machines has a negative 23.1% quarter-over-quarter sales growth and a negative 1.1% the following.

Dividend Yield

Morningstar, Inc. claims that the next dividend payment will be on August 8, 2022. The forward dividend rate and yield are estimated to be 6.6 and 5.05%, respectively.

More news about International Business Machines.

18. Genmab (GMAB)

Shares of Genmab jumped by a staggering 16.3% in from $37.66 to $43.80 at 21:29 EST on Monday, following the last session’s downward trend. NASDAQ is sliding 1.09% to $11,024.51, following the last session’s downward trend.

Genmab A/S is a Danish company that develops and markets antibody therapies for cancer treatment.

Earnings per Share

Genmab’s trailing 12 months profit per share is $0.66

PE Ratio

Genmab’s trailing 12-month price-to-earnings ratio is 66.25. The purchaser of the shares is therefore investing $66.25 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 17.71%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 60.3%, now sitting on 10.21B for the twelve trailing months.

Yearly Top and Bottom Value

Genmab’s stock is valued at $43.80 at 21:31 EST, under its 52-week high of $43.88 and way above its 52-week low of $26.19.

Moving Average

Genmab’s value is way higher than its 50-day moving average of $37.24 and way higher than its 200-day moving average of $34.63.

Volume

Today’s last reported volume for Genmab is 164920 which is 72.01% below its average volume of 589293.

More news about Genmab.

19. AT&T (T)

Shares of AT&T rose 7.71% in from $17.5 to $18.85 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

AT&T Inc. offers telecommunications and media services around the world.

Earnings per Share

AT&T’s trailing 12 months profit per share is $-0.34.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 11.92%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AT&T’s stock is considered to be oversold (<=20).

More news about AT&T.

20. Enphase Energy (ENPH)

Shares of Enphase Energy jumped by a staggering 19.55% in from $253.34 to $302.87 at 21:29 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ is dropping 1.09% to $11,024.51, following the last session’s downward trend.

Enphase Energy, Inc., along with its affiliates, designs, produces, markets, and supports the sale of home energy solutions in the solar photovoltaic sector.

Earnings Per Share

As for profitability, Enphase Energy has a trailing twelve months EPS of $0.67.

PE Ratio

Enphase Energy has a trailing twelve months price to earnings ratio of 450.03. Meaning,
the purchaser of the share is investing $450.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.1%.

Moving Average

Enphase Energy’s worth is higher than its 50-day moving average of $283.05 and way above its 200-day moving average of $223.26.

Volume

Enphase Energy’s current reported volume is 1324210, which is 6.4% lower than its usual volume of 3946380.

Volatility

Enphase Energy’s last week, last month’s, and last quarter’s current intraday variation average was 0.61%, 0.99%, and 2.79%.

Enphase Energy’s highest amplitude of average volatility was 1.40% (last week), 3.24% (last month), and 2.79% (last quarter).

More news about Enphase Energy.

21. STMicroelectronics (STM)

Shares of STMicroelectronics rose by a staggering 12.38% in from $33.67 to $37.84 at 21:29 EST on Monday, after four successive sessions in a row of losses. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

STMicroelectronics N.V. and its subsidiaries design, develop, manufacture, and market semiconductor products throughout Europe, Africa, America, Europe, the Middle East and Asia Pacific.

Earnings Per Share

As for profitability, STMicroelectronics has a trailing twelve months EPS of $1.38.

PE Ratio

STMicroelectronics has a trailing twelve months price to earnings ratio of 27.42. Meaning,
the purchaser of the share is investing $27.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.01%.

Annual Top and Bottom Value

STMicroelectronics shares are valued at $37.84 as of 21:31 EST. This is way lower than its 52 week high of $52.15, and much higher than its 52 week low of $28.35.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

STMicroelectronics stocks are considered oversold (=20).

Volatility

STMicroelectronics had a negative 0.422% in the last week and last month, respectively, as well as a positive 0.60% and positive 2.45% for last quarter.

STMicroelectronics had the highest average volatility amplitudes at 1.34%, 2.80% and 2.45% respectively.

More news about STMicroelectronics.

22. AMD (AMD)

Shares of AMD jumped by a staggering 23.54% in from $58.58 to $72.37 at 21:29 EST on Monday, after two successive sessions in a row of losses. NASDAQ is falling 1.09% to $11,024.51, following the last session’s downward trend.

Advanced Micro Devices, Inc. is a worldwide semiconductor company.

Earnings per Share

AMD’s trailing 12 month EPS is $2.38.

PE Ratio

AMD’s trailing 12-month price-earnings ratio is 30.38. The purchaser of the shares is investing $30.38 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is an indicator of the business’ profitability relative to shareholders’ equity, was 7.37%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29%, now sitting on 22.83B for the twelve trailing months.

Volume

Today’s last reported volume for AMD is 21725400 which is 74.31% below its average volume of 84580500.

Annual Top and Bottom Value

AMD stock was valued at $72.37 as of 21:31 EST at 21.31 EST. This is way lower than the 52-week high $164.46, and much higher than the 52-week low $54.57.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AMD’s EBITDA is 5.08.

More news about AMD.

23. TE Connectivity (TEL)

Shares of TE Connectivity rose 7.96% in from $115.53 to $124.73 at 21:29 EST on Monday, after two sequential sessions in a row of losses. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

TE Connectivity Ltd. and its subsidiaries manufacture and sell connectivity and sensor solutions throughout Europe, Africa, Asia-Pacific and Americas.

Earnings per Share

TE Connectivity’s trailing 12 month EPS is $3.24.

PE Ratio

TE Connectivity’s trailing 12-month price-to-earnings ratio is 38.51. The purchaser of the shares is therefore investing $38.51 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability of a company relative to shareholders’ equity, was 24.28%.

More news about TE Connectivity.

24. Lumen Technologies (LUMN)

Shares of Lumen Technologies slid by a staggering 16.61% in from $6.93 to $5.78 at 21:29 EST on Monday, after four sequential sessions in a row of losses. NYSE is falling 0.21% to $15,278.26, following the last session’s downward trend.

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally.

Earnings Per Share

As for profitability, Lumen Technologies has a trailing twelve months EPS of $-0.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.68%.

More news about Lumen Technologies.

25. Visa (V)

Shares of Visa rose 8.46% in from $190.35 to $206.45 at 21:29 EST on Monday, after four sequential sessions in a row of losses. NYSE is dropping 0.21% to $15,278.26, following the last session’s downward trend.

Visa Inc. is a global payments technology company.

Earnings Per Share

As for profitability, Visa has a trailing twelve months EPS of $4.84.

PE Ratio

Visa has a trailing twelve months price to earnings ratio of 42.67. Meaning,
the purchaser of the share is investing $42.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.85%.

Dividend Yield

Morningstar, Inc. has stated that the next dividend payment will be made on May 11, 2022. The forward dividend rate for 2020 is estimated at 1.5, and the forward dividend yield to be 0.71%.

Volume

The last Visa volume reported today is 363480, which is 47.61% lower than its usual volume of 6938390.

Yearly Top and Bottom Value

Visa’s stock is valued at $206.45 at 21:32 EST, way under its 52-week high of $236.96 and way higher than its 52-week low of $182.23.

Revenue growth

The year-over-year revenue growth was 18.7%. We now have 28.08B in the 12 trailing months.

More news about Visa.

26. Amkor Technology (AMKR)

Shares of Amkor Technology jumped by a staggering 39.81% in from $19.67 to $27.50 at 21:29 EST on Monday, after two successive sessions in a row of losses. NASDAQ is dropping 1.09% to $11,024.51, following the last session’s downward trend.

Amkor Technology, Inc. offers outsourced semiconductor packaging services and testing in the United States, Japan, Europe, Africa, Europe, Middle East, Africa, and other parts of Asia Pacific.

Earnings per Share

Amkor Technology’s trailing 12 months profit per share is $1.63

PE Ratio

Amkor Technology’s trailing 12-month price-earnings ratio is 16.89. The purchaser of the shares is investing $16.89 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability of a company relative to shareholders’ equity, was 26.14%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 42.9% and a drop 23.2% for the next.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

Amkor Technology stock considered overbought (>=80).

More news about Amkor Technology.